Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase 3 11Phase 1 11Phase NA 6Phase 2/3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 4INDUSTRY 3OTHER_GOV 1OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Lymphoma 4Colorectal Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia 2Xerostomia 1Warts 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Tongue Neoplasms 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Stomach Neoplasms 1Sezary Syndrome 1Seminoma 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Salivary Gland Neoplasms 1Recurrent Squamous Cell Lung Carcinoma 1Recurrence 1Prostatic Neoplasms 1Previously Treated Non-Small Cell Lung Cancer 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Pain 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × NETWORK × Fallopian Tube Neoplasms × Clear all
NCT01506856 2023-09-15

iPocc

Gynecologic Oncology Trial & Investigation Consortium

Phase 2/3 Completed
655 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡